[{"Assets_0_Q1_USD":"4722841000.0","CIK":"1048477","CommonStockSharesIssued_0_Q1_shares":"180761969.0","CommonStockSharesOutstanding_0_Q1_shares":"180761969.0","Country":"United States","EarningsPerShareBasic_1_Q1_USD":"0.45","EarningsPerShareDiluted_1_Q1_USD":"0.44","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","Market Cap":"14899091235.0","NetCashProvidedByUsedInOperatingActivitiesConverted_1_Q1_USD":"-15194000.0","NetIncomeLossAvailableToCommonStockholdersBasic_1_Q1_USD":"81381000.0","NetIncomeLoss_1_Q1_USD":"81381000.0","OfficialName":"BioMarin Pharmaceutical Inc. Common Stock","RevenuesConverted_1_Q1_USD":"502069000.0","SP500":null,"Sector":"Health Care","StockholdersEquity_0_Q1_USD":"3239962000.0","Ticker":"BMRN","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":"187163000.0","WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":"179898000.0","filed":"20200501","footnote":null,"form":"10-Q","fp":"Q1","fy":"2020.0","name":"BIOMARIN PHARMACEUTICAL INC","period":"20200331","qtrs":"0","uom":"USD"}]